Labs & Departments

Today's Discoveries. Tomorrow's Healing.
Three members of the Raghavan lab team examine the contents of a tube

The U-M Medical School's deeply integrated research ecosystem fosters collaborations — across disciplines, and with the University of Michigan, external partners, stakeholders and communities.

Search

Search our many research areas by keyword, or browse by category below.
Start here
Artificial Intelligence (AI) Diabetes Heart Disease Neuroscience Rogel Cancer Center

Browse by category

firefly

Departments

Throughout 20 clinical and nine basic science departments, teaching, research and clinical care often cross traditional departmental boundaries.

  • Browse our departments
  • rogel_cancer_center_lab

    Centers & Institutes

    Our interdisciplinary centers, institutes and programs foster opportunities for creative research and educational collaborations.

  • Browse Our Centers & Institutes
  • Two people in lab coats working on a project

    Labs

    The labs at Michigan Medicine are at the heart of our research work.  With 600+ labs in operation, we work across the realm of cutting-edge science.

  • Browse our labs
  • Med Campus

    Research Facilities

    Our research-focused and patient-focused facilities are thoughtfully designed to cultivate collaboration and drive innovation.

  • Browse our research facilities
  • Research supplies on a shelf

    Research at a Glance

    Research Awards

    Other research figures include $507.8M in NIH awards (FFY25), $828.5M in sponsored project awards and $163.4M in industry sponsored awards.
    Learn More About Our Research Impact
    $753.8M
    Sponsored Project Expenditures
    1,899
    Active Clinical Trials
    188
    Invention Reports

    Research News & Stories

    More Research News
    Minding memory above a microphone on a blue background
    Minding Memory

    Giving Voice to Lived Experience in Dementia Research

    In this episode, Lauren & Matt talk to Brenda Roberts and Steven Barbieri from the National Council of Dementia Minds. The National Council of Dementia Minds is the first national not-for-profit organization founded and governed by people living with dementia. Its work focuses on education, advocacy, peer support, and changing public perception of what it means to live with dementia. Brenda and Steven talk about the National Council of Dementia Minds, the importance of peer support and education for people living with dementia. They focus on how better understanding the lived experiences of people living with dementia can help shape research, policy, and advocacy.
    UMich Med Mosaic on blue background with colorful geometric shapes
    UMich Med Mosaic

    Beyond the White Coat: Disability, Neurodiversity and Advocacy in Medical School

    In this episode of UMich Med Mosaic, host Mackenzie Kay sits down with medical students Jill Maudlin, Sarah Renberg and Bella Johnson to discuss their experiences as disabled and neurodivergent trainees at the University of Michigan Medical School. They reflect on the personal journeys that led them to medicine, the challenges and strengths that accompany living with disabilities and chronic health conditions and the importance of representation within the medical profession. The conversation explores how disability shapes their approaches to patient care, advocacy and teamwork, as well as the role of the Medical Students for Disability Health Advocacy (MSDHA) organization in creating community and advancing accessibility initiatives. They also discuss Michigan’s accommodations in medical education, efforts to improve disability-related curriculum content and the importance of building a culture where disabled and neurodivergent students can thrive.
    Minding Memory with a microphone and a shadow of a microphone on a blue background
    Minding Memory

    Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

    In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
    Well-Being at Michigan Medicine with Dr. Elizabeth Harry
    Well-Being at Michigan Medicine

    Learning Together: Making Space for Growth at Work

    What if well-being starts with how we learn together? On this episode of Well-Being at Michigan Medicine, Elizabeth Harry, M.D., is joined by Rajesh Mangrulkar, M.D., FNAP, Executive Director of U-M’s Center for Interprofessional Practice and Education (IPE), Executive Director of Michigan Medicine RISE (Research. Innovation. Scholarship. Education), and primary care physician of internal medicine whose work focuses on organizational leadership and innovation, and Johnny McGraw, M.A., Marketing & Communications Specialist for both RISE and IPE, about building teams through human connection, psychological safety and learning. They discuss a meeting practice, why leaders shape culture and how investments in collaboration can help health care teams work without asking people to carry everything alone.
    Two U-M faculty headshots with the titling, National Academy of Medicine, presented above their names: Diane Harper and Jacqueline Jeruss.
    News Release

    Two U-M Researchers Earn Election to National Academy of Medicine

    Two U-M Researchers Earn Election to National Academy of Medicine
    pattern up close sequencing gene navy yellow
    Health Lab

    Comprehensive DNA sequencing reveals hidden drivers of cancer

    Two research papers describe how long-read nanopore sequencing can detect alterations in cancer cells that might be missed by conventional sequencing.